Alan Dunton
Non-Executive Director / Cambium Bio
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 397th | Vmoto | 66.32% | -24.24% |
| 398th | Cynata Therapeutics | 65.58% | -12.41% |
| 399th | Recce Pharmaceuticals | 65.5% | -15.11% |
| 400th | Perseus Mining | 65.33% | 37.16% |
| 401st | Fat Prophets Global Contrarian Fund | 64.61% | 4.81% |
| NEW ROLE: Non-Executive Director, Cambium Bio | 03 Nov 2020 | |
| NEW ROLE: Non-Executive Director, Recce Pharmaceuticals | 18 Aug 2020 |
Access to our data for Alan Dunton is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Alan Dunton is linked to 2 organisations which are included in 1 list - Public Companies - non WA.
To see the data you will need to Subscribe.